Author

Yosui Tamaki

Observed names: Yosui TAMAKI, タマキ, ヨウスイ

Institutions: Asahikawa Medical University, National Hospital Organization Asahikawa Medical Center

Observed institutions: Dokkyo University, Asahikawa Medical College Hospital, Asahikawa Medical University, National Hospital Organization Asahikawa Medical Center, Asahikawa University, Obihiro University of Agriculture and Veterinary Medicine, Dokkyo Medical University

ORCID: 0009-0007-7126-7027

Observed ORCID: 0009-0007-7126-7027

OpenAlex ID: A5113598692

Inhibitory effect of angiotensin II receptor antagonist on hepatic stellate cell activation in non-alcoholic steatohepatitis

2006 · Shiro Yokohama, Yoshihiko Tokusashi, et al. · World Journal of Gastroenterology · 104

PDF

Angiotensin II type 1 receptor antagonist prevents hepatic carcinoma in rats with nonalcoholic steatohepatitis

2012 · Yosui Tamaki, Yukiomi Nakade, et al. · Journal of Gastroenterology · 57

Extracellular vesicle-encapsulated miR-30e suppresses cholangiocarcinoma cell invasion and migration via inhibiting epithelial-mesenchymal transition

2018 · Yu Ota, Kenji Takahashi, et al. · Oncotarget · 42

PDF

Hepatic schwannoma: imaging findings on CT, MRI and contrast-enhanced ultrasonography.

2012 · Yu Ota, Kazunobu Aso, et al. · PubMed · 26

Sa1818 Extracellular Vesicle-Encapsulated Long Non-Coding RNA HULC Modulates Epithelial-Mesenchymal Transition in Human Pancreatic Cancer

2015 · Kenji Takahashi, Yu Ota, et al. · Gastroenterology · 4

PDF

Extracellular RNA transfer from non‐malignant human cholangiocytes can promote cholangiocarcinoma growth

2021 · Yu Ota, Kenji Takahashi, et al. · FEBS Open Bio · 3

Different Associations of Plasma Lipopolysaccharide and Lipopolysaccharide-Binding Protein Concentrations with the Deterioration of Energy Metabolism from Healthy Individuals to Patients with Non-Alcoholic Fatty Liver Disease

2026 · Nobuo Fuke, Yosui Tamaki, et al. · Metabolites

Sa1063 Comparative Study of Anti-Peristaltic Agents for Upper Gastrointestinal Endoscopy

2016 · Keisuke Yamakita, Yohei Kitano, et al. · Gastrointestinal Endoscopy

Tu1052 Prognostic Value of Contrast-Enhanced Ultrasonography in Patients With Small Hepatocellular Carcinoma

2013 · Yu Ota, Yosui Tamaki, et al. · Gastroenterology

S1907 Accuracy of Contrast-Enhanced Ultrasonography With Sonazoid in Gross Classification of Hepatocellular Carcinoma

2010 · Yosui Tamaki, Kazunobu Aso, et al. · Gastroenterology

783 Angiotensin II Type 1 Receptor Antagonist Attenuates Hepatic Carcinogenesis in Nonalcoholic Steatohepatitis in Rats

2008 · Yosui Tamaki, Yukiomi Nakade, et al. · Gastroenterology

Acute renal failure in a HCV cirrhotic patient receiving interferon therapy

2004 · Shiro YOKOHAMA, Yosui TAMAKI, et al. · Kanzo

PDF

Endogenous prostaglandins plays a role in concanavalin A-induced liver injury in mice

2004 · Satoshi Okamoto, Yosui Tamaki, et al. · Yakuri to chiryō

High molecular weight but not low molecular weight hyaluronan prevents concanavalin a-induced liver injury by reducing proinflammatory cytokines in mice

2003 · Kimihide Nakamura, Shiro Yokohama, et al. · Gastroenterology

Interleukin 7 exacerbates concanavalin a-induced liver injury and cytokines production in immature mice

2003 · Kimihide Nakamura, Yosui Tamaki, et al. · Gastroenterology

Macrophage inflammatory protein-1α (MIP-1α) enhances experimental liver injury through induction of proinflammatory cytokines in mice

2003 · Shiro Yokohama, Yosui Tamaki, et al. · Gastroenterology

PDF

continuous immune tolerance on liver injury is induced by repeated intravenous injection with concanavalin a in mice

2003 · Yosui Tamaki, Kimihide Nakamura, et al. · Gastroenterology

PDF

Works count: 18

Citation count: 236

H-index: 4

I10-index: 4